Brussels, 25 March 2021
(OR. en)
SN 18/21
Statement of the Members of the European Council
I.
1.
COVID-19
Accelerating the production, delivery and deployment of vaccines remains essential and
urgent to overcome the crisis. Efforts to this end must be further intensified. We underline the
importance of transparency as well as of the use of export authorisations. We recognise the
importance of global value chains and reaffirm that companies must ensure predictability of
their vaccine production and respect contractual delivery deadlines. We confirm the pro-rata
population key for the allocation of vaccines. We invite the Committee of Permanent
Representatives to address the issue of the speed of deliveries of vaccines when allocating the
10 million BioNTech-Pfizer accelerated doses in the second quarter of 2021 in a spirit of
solidarity.
SN 18/21
1
EN